There are 1105 resources available
607P - Results from a feasibility pilot for integrated TB & lung cancer screening in Vietnam
Presenter: Andrew Codlin
Session: Poster Display session
Resources:
Abstract
608P - Timing of surgery after neoadjuvant immunochemotherapy in non-small cell lung cancer is crucial for outcome
Presenter: Jiayi Wang
Session: Poster Display session
Resources:
Abstract
609P - Camrelizumab plus platinum doublet chemotherapy as adjuvant treatment of stage IIA-IIIA non-small cell lung cancer: A phase II, single-arm research
Presenter: Hai Xu
Session: Poster Display session
Resources:
Abstract
610P - Relapse pattern of NSCLC after neoadjuvant immunotherapy
Presenter: Xinchen Tan
Session: Poster Display session
Resources:
Abstract
611P - Cost-effectiveness of perioperative ICI therapy with NSCLC in Japan, USA, Brazil
Presenter: Toshihiko Aranishi
Session: Poster Display session
Resources:
Abstract
612P - Adjuvant targeted therapy vs. continued immunochemotherapy in NSCLC with actionable driver mutations detected after neoadjuvant immunochemotherapy
Presenter: Hongsheng Deng
Session: Poster Display session
Resources:
Abstract
613TiP - Evaluation of low dose Nivolumab with neoadjuvant chemotherapy in non-small cell lung cancer: A phase II open label randomised clinical trial (ELON)
Presenter: NIRANJAN BISWAL
Session: Poster Display session
Resources:
Abstract
615P - Treatment (Tx) patterns and clinical outcomes in unresectable (UR) stg III EGFR-mutation positive (EGFRm) NSCLC treated with chemoradiotherapy (CRT): Final analysis of a global real-world (rw) study
Presenter: Jii Bum Lee
Session: Poster Display session
Resources:
Abstract
616P - Osimertinib after definitive chemoradiotherapy (CRT) in patients (pts) with unresectable (UR) stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC): Post-progression outcomes from the phase III LAURA study
Presenter: James Chih-Hsin Yang
Session: Poster Display session
Resources:
Abstract
617P - Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101)
Presenter: Hajime Kikuchi
Session: Poster Display session
Resources:
Abstract